Skip to main content
Premium Trial:

Request an Annual Quote

Greg Hannon

Cancer Research UK and the University of Cambridge recently announced Greg Hannon as the new director of the Cancer Research UK Cambridge Institute. Hannon joined the Cancer Research UK Cambridge Institute in 2014 as a senior group leader. Prior to that he spent more than 20 years at Cold Spring Harbor Laboratory where he was a Howard Hughes Medical Institute Investigator and chaired the cancer genetics program as part of the Lab's National Cancer Institute-designated cancer center.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.